Anti-Hu CD329 APC

*O'Sullivan JA, Carroll DJ, Cao Y, Salicru AN, Bochner BS: Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells. J Allergy Clin Immunol. 2018 May;141 (5) :1774-1785, URL: https://pubmed.ncbi.nlm.nih.gov/28734845/, *Hudak JE, Canham SM, Bertozzi CR: Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat Chem Biol. 2014 Jan;10 (1) :69-75., URL: https://pubmed.ncbi.nlm.nih.gov/24292068/, *Avril T, Floyd H, Lopez F, Vivier E, Crocker PR: The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells. J Immunol. 2004 Dec 1;173 (11) :6841-9. , URL: https://pubmed.ncbi.nlm.nih.gov/15557178/

The mouse monoclonal antibody K8 recognizes an extracellular epitope of CD239, a type I transmembrane glycoprotein expressed above all on monocytes, neutrophils, and a minor population of CD16+CD56- cells.